simendan has been researched along with esmolol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alhashemi, JA | 1 |
| Baldassarri, R; Guarracino, F; Landoni, G; Nobile, L; Stefani, M | 1 |
2 other study(ies) available for simendan and esmolol
| Article | Year |
|---|---|
Treatment of cardiogenic shock with levosimendan in combination with beta-adrenergic antagonists.
Topics: Adrenergic beta-Antagonists; Cardiotonic Agents; Drug Therapy, Combination; Humans; Hydrazones; Male; Middle Aged; Myocardial Infarction; Propanolamines; Pyridazines; Shock, Cardiogenic; Simendan | 2005 |
Concomitant levosimendan and esmolol infusion in ischaemic cardiogenic shock.
Topics: Adrenergic beta-Antagonists; Cardiotonic Agents; Drug Therapy, Combination; Humans; Hydrazones; Male; Middle Aged; Myocardial Infarction; Propanolamines; Pyridazines; Shock, Cardiogenic; Simendan | 2010 |